# State Street SPDR S&P Pharmaceuticals ETF (XPH)

> Source: Nexqual · https://nexqual.com/XPH · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, State Street SPDR S&P Pharmaceuticals ETF (XPH), nexqual.com/XPH" · informational, not investment advice.

**Price:** USD 62.7 (-2.46% on the day) · last close of Oct 23, 2026; US market after hours, not a live price. Prev close 64.28 · day 62.46–63.8 · 52w 47.6–74.35 · market cap null · PCX

## Key facts
- Total return with dividends: 1Y +29.3% vs S&P 500 +13.4%; 5Y +39.1% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +29.3% | +39.1% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +29.4% | +6.8% |
| Volatility (annualized) | 23.6% | 20.5% |
| Max drawdown | -16.4% (Aug 2026→Oct 2026) | -29.9% (Nov 2021→Nov 2023) |

## Peers
IHE (iShares U.S. Pharmaceutical ETF) USD 102.51 -2.17% · PJP (Invesco Pharmaceuticals ETF) USD 125.03 -1.79% · XHS (State Street SPDR S&P Health Ca) USD 141.4 -0.90% · XHE (State Street SPDR S&P Health Ca) USD 93.08 -0.28% · XES (State Street SPDR S&P Oil & Gas) USD 109.12 +4.65%

## More
Full page: https://nexqual.com/XPH · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt